Avacta Group Share News (AVCT)

Avacta Group Information

Buy AVCT Shares
Add AVCT to Watchlist
Add AVCT to Alert

Share Price Information for Avacta Group (AVCT)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 39.75

Bid: 39.50

Ask: 40.00

Change: -0.50 (-1.24%)

Spread: 0.50 (1.266%)

Open: 40.25

High: 40.25

Low: 39.75

Prev. Close: 40.25

Last checked at -

IN BRIEF: Avacta shareholders give AGM go-ahead to issue new shares

Mon, 18th Mar 2024 14:31

Avacta Group PLC - Wetherby, England-based life sciences company developing oncology drugs and diagnostics - At annual general meeting on Monday, shareholders approved the resolution to issue 23.9 million placing shares and 10.9 million Rex offer share, both at 50 pence each. This raises gross proceeds of around GBP11.9 million and GBP5.4 million respectively. Combined with proceeds from an earlier firm placing and direct subscription, the shares for which were admitted to trading on March 4, Avacta has raised total gross proceeds of GBP31.1 million.

Current stock price: 51.00 pence, down 2.4% on Monday afternoon

12-month change: down 58%

By Emma Curzon, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

More News

14 Jul 2016 08:34

Avacta Collaborating With Glythera To Develop Antibody Drugs

22 Jun 2016 10:54

Avacta claims development could lead to early Zika diagnosis

(ShareCast News) - Avacta, biotherapeutics and research agent developer, reported on Wednesday it had identified three proteins which could be used to develop the first tests to diagnose early stages of the Zika virus. Avacta said it found three 'Affimer' proteins capable of binding to a form of sec

22 Jun 2016 06:37

Avacta Identifies Affimer Proteins For Possible Zika Virus Tests

13 Jun 2016 08:23

Avacta Forms Partnership With Mologic To Develop Point-Of-Care Tests

29 Apr 2016 14:37

DIRECTOR DEALINGS: Avacta Chief Operating Officer Buys Shares

25 Apr 2016 08:22

Avacta Making Good Progress On Programmes As Interim Loss Widens

19 Apr 2016 09:27

Avacta Group Hails Milestone In Multi-Affimer Production

18 Apr 2016 15:05

Earnings, Trading Statements Calendar - Week Ahead

7 Mar 2016 15:39

Avacta appoints scientific advisory board

(ShareCast News) - Avacta Group established what it saw as one of the last pieces in the management puzzle to get its products towards the market, appointing professors Terence Rabbitts, Paul Moss and Adrian Hayday to form the company's scientific advisory board on Monday. The AIM-traded developer o

24 Feb 2016 08:56

Latest Share Chat

Avacta Group Share News (AVCT)

Share Price Information for Avacta Group (AVCT)

IN BRIEF: Avacta shareholders give AGM go-ahead to issue new shares

Avacta Collaborating With Glythera To Develop Antibody Drugs

Avacta claims development could lead to early Zika diagnosis

Avacta Identifies Affimer Proteins For Possible Zika Virus Tests

Avacta Forms Partnership With Mologic To Develop Point-Of-Care Tests

DIRECTOR DEALINGS: Avacta Chief Operating Officer Buys Shares

Avacta Making Good Progress On Programmes As Interim Loss Widens

Avacta Group Hails Milestone In Multi-Affimer Production

Earnings, Trading Statements Calendar - Week Ahead

Avacta appoints scientific advisory board

Avacta Gets Grant For Work To Help Reduce Use Of Animal Testing

Avacta Poaches Abcam's Cotrel For Chief Commercial Officer Role

Avacta Group Proposes 1-For-10 Share Consolidation (ALLISS)

Avacta Appoints Tony Gardiner As Chief Financial Officer

BROKER RATINGS SUMMARY: Investec Raises Senior To Buy From Hold

Avacta Full-Year Loss Widens As It Ramps Up Affimer Investment

Latest Share Chat

Avacta Group Share News (AVCT)

Share Price Information for Avacta Group (AVCT)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IN BRIEF: Avacta shareholders give AGM go-ahead to issue new shares

Login to your account

Quickpicks are a member only feature

Login to your account